Manulife (Manufacturers Life Insurance)
CRDF icon

Manulife (Manufacturers Life Insurance)’s Cardiff Oncology CRDF Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.2K Sell
18,624
-812
-4% -$1.67K ﹤0.01% 2778
2025
Q4 		$54.6K Buy
19,436
+5,696
+41% +$13.2K ﹤0.01% 2802
2025
Q3 		$28.3K Sell
13,740
-8,216
-37% -$22.7K ﹤0.01% 2898
2025
Q2 		$69.2K Buy
21,956
+4,232
+24% +$12.9K ﹤0.01% 2836
2025
Q1 		$55.7K Buy
17,724
+2,237
+14% +$8.85K ﹤0.01% 2814
2024
Q4 		$67.2K Buy
+15,487
New +$48.4K ﹤0.01% 2892
2022
Q2 		– Sell
-10,353
Closed -$25.7K – 3035
2022
Q1 		$25.7K Sell
10,353
-12,266
-54% -$43.4K ﹤0.01% 3060
2021
Q4 		$136 Sell
22,619
-2,234
-9% -$13.3K ﹤0.01% 3003
2021
Q3 		$166K Buy
24,853
+2,350
+10% +$14.8K ﹤0.01% 3043
2021
Q2 		$150K Buy
+22,503
New +$191K ﹤0.01% 3190
2017
Q3 		– Sell
-17
Closed -$2K – 4247
2017
Q2 		$2K Sell
17
-1
-6% -$64 ﹤0.01% 4106
2017
Q1 		$1K Hold
18
– – ﹤0.01% 4024
2016
Q4 		$3K Sell
18
-197
-92% -$46K ﹤0.01% 4028
2016
Q3 		$70K Buy
215
+197
+1,094% +$71.8K ﹤0.01% 3330
2016
Q2 		$6K Sell
18
-276
-94% -$95.1K ﹤0.01% 3748
2016
Q1 		$100K Buy
294
+29
+11% +$9.87K ﹤0.01% 3038
2015
Q4 		$103 Hold
265
– – ﹤0.01% 3080
2015
Q3 		$108 Buy
265
+43
+19% +$22.5K ﹤0.01% 3092
2015
Q2 		$163 Buy
222
+220
+11,000% +$156K ﹤0.01% 3029
2015
Q1 		$1 Hold
2
– – ﹤0.01% 3878
2014
Q4 		$1 Sell
2
-31
-94% -$10K ﹤0.01% 3818
2014
Q3 		$11 Buy
33
+23
+230% +$6.88K ﹤0.01% 3493
2014
Q2 		$2K Hold
10
– – ﹤0.01% 3691
2014
Q1 		$4 Hold
10
– – ﹤0.01% 3531
2013
Q4 		$4 Hold
10
– – ﹤0.01% 3568
2013
Q3 		$5 Hold
10
– – ﹤0.01% 3355
2013
Q2 		$5K Buy
+10
New +$4.52K ﹤0.01% 3267

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CRDF Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Cardiff Oncology (CRDF) stake by 4.2% in Q1 2026, selling an estimated $1.67K and leaving 18,624 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2778.

Manulife (Manufacturers Life Insurance) first reported a position in CRDF in Q2 2013 and has held it in 27 quarters since. The position peaked at $166K in Q3 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 18,624 shares of Cardiff Oncology worth $30.2K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 812 Cardiff Oncology shares in Q1 2026, an estimated $1.67K.
  • Cardiff Oncology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2778 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cardiff Oncology in Q2 2013 and has held it in 27 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Cardiff Oncology position peaked at $166K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.